ASCO: Drug Combo Ups Progression-Free Survival for Metastatic Prostate Cancer
Improvement in radiographic progression-free survival seen for talazoparib plus enzalutamide as first-line treatment
ASCO: Extended Lymph Node Removal Not Beneficial for Bladder Cancer
No benefit in terms of disease-free or overall survival seen for those with muscle-invasive bladder cancer undergoing radical cystectomy
Genetically Adjusted PSA Levels Improve Prediction of Prostate Cancer
Genetically adjusted prostate-specific antigen more predictive of aggressive prostate cancer than unadjusted PSA
FDA Approves Lynparza for BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer
Approval is for Lynparza with abiraterone and prednisone (or prednisolone)
Certain Factors Increase Risk for UTIs After Radical Hysterectomies
Findings show smoking and seven or more days of catheter use independently increase risk
8.2 Percent of Adults Do Not Take Meds as Prescribed Due to Cost
Likelihood of not taking medication as prescribed due to cost increased for women versus men and for those with disabilities
Biden Set to Name New CDC Director
Former North Carolina Health Secretary Mandy Cohen is the likely pick
Healthy Lifestyle Does Not Entirely Offset Risks for Obesity
Decreased risk seen for cardiovascular disease, kidney failure, gout, sleep disorders, and mood disorders
Aquablation Procedure Safe for BPH, With Durable Efficacy
Significant improvement seen in patient symptoms at five years; improvement also seen in mean maximum urinary flow rate
Stress-Management Interventions May Aid Health Care Workers
Review generally revealed low-certainty evidence, particularly for longer-term effects
